Report: Macrocure To Move Headquarters To New Jersey

August 16, 2015 | The Israeli biopharmaceutical company Macrocure is reportedly considering moving its headquarters to New Jersey. The Economic Development Authority (EDA) awarded Macrocure Grow NJ tax credits worth up to $3.2 million over the next ten years to encourage Macrocure to establish their headquarters in New Jersey. If the deal goes through, Macrocure will establish its offices in the EDA’s Technology Center of New Jersey in North Brunswick. Macrocure was founded in 2008 and is currently headquartered in Petah Tikvah, Israel.